Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin for Bile Acid Metabolism in PSC
NCT02464020Phase 1Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2015
- Primary completion
- May 2017
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of vancomycin in Primary Sclerosing Cholangitis (PSC) (2 arms), sponsored by University of Minnesota. Primary endpoint: Fecal bile acid composition at 5 days. Started Jul 2015; status: completed.
02
Drugs
vancomycin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT02464020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464020.